Key Insights
The Vietnamese diabetes care devices market, valued at $424.10 million in 2025, is projected to experience steady growth, driven by rising prevalence of diabetes, increasing awareness of blood glucose monitoring, and government initiatives promoting better diabetes management. A compound annual growth rate (CAGR) of 2.10% is anticipated from 2025 to 2033, indicating a gradual but consistent expansion. Key segments driving this growth include self-monitoring blood glucose devices (SMBG), which currently hold a significant market share due to their affordability and ease of use. Continuous glucose monitoring (CGM) systems are also gaining traction, albeit at a slower pace, due to higher costs and limited accessibility. The insulin delivery segment, encompassing insulin pumps, infusion sets, syringes, cartridges, and pens, contributes substantially to the overall market value, influenced by the increasing number of insulin-dependent diabetic patients. Major players like Roche, Abbott, Medtronic, and Novo Nordisk are actively competing in this market, focusing on technological advancements and product diversification to capture market share. Growth may be constrained by factors such as high treatment costs, limited healthcare infrastructure in certain regions, and the need for greater patient education and awareness regarding the benefits of proactive diabetes management.
This market demonstrates a clear opportunity for growth, particularly with increased investment in healthcare infrastructure and public health programs aimed at addressing diabetes. The increasing adoption of technologically advanced devices, including CGM systems with improved accuracy and user-friendliness, will be crucial drivers of future market expansion. Furthermore, strategic partnerships between manufacturers and healthcare providers, focused on improving patient access and affordability, are key to unlocking the full potential of the Vietnamese diabetes care devices market. The presence of established global players alongside the potential for local market entrants creates a dynamic landscape characterized by both competition and collaboration.
Diabetes Care Devices Industry in Vietnam: A Comprehensive Market Report (2019-2033)
This in-depth report provides a comprehensive analysis of the Vietnam diabetes care devices market, offering invaluable insights for industry professionals, investors, and strategic planners. The report covers the period 2019-2033, with a focus on the 2025-2033 forecast period, leveraging data from the base year 2025 and historical data from 2019-2024. Expect detailed analysis on market size, segmentation, growth drivers, challenges, and key players, including Roche, Dexcom, Abbott, and more. The report includes a granular examination of market segments and competitive dynamics, providing actionable intelligence to navigate this rapidly evolving market.
Diabetes Care Devices Industry in Vietnam Market Structure & Innovation Trends
The Vietnamese diabetes care devices market exhibits a moderately concentrated structure, with key players like Roche, Abbott, and Novo Nordisk holding significant market share. The exact market share distribution is analyzed in the full report, showing a 7-2 company share analysis for 2025. Innovation is driven by the rising prevalence of diabetes, government initiatives to improve healthcare access, and technological advancements in continuous glucose monitoring (CGM) and insulin delivery systems. The regulatory framework, while evolving, generally supports market growth. The market sees some substitution with traditional methods, however, the demand for advanced devices is increasing. The end-user demographic is largely skewed towards older adults, but the increasing prevalence of Type 1 diabetes among younger populations is shaping market trends. Mergers and acquisitions (M&A) activity is moderate, with deal values ranging from xx Million to xx Million in recent years (detailed data in the full report).
Diabetes Care Devices Industry in Vietnam Market Dynamics & Trends
The Vietnamese diabetes care devices market is experiencing robust growth, with a projected Compound Annual Growth Rate (CAGR) of xx% during the forecast period (2025-2033). This growth is fueled by several factors: the rising prevalence of diabetes (both Type 1 and Type 2) due to changing lifestyles and an aging population; increasing healthcare expenditure; rising awareness about diabetes management; and government initiatives to improve access to quality healthcare. Technological disruptions, such as the introduction of advanced CGM systems like Abbott's FreeStyle Libre, are significantly impacting market dynamics, driving higher market penetration and improved patient outcomes. Consumer preferences are shifting towards user-friendly, accurate, and minimally invasive devices. Competitive dynamics are characterized by intense rivalry among multinational corporations and a growing presence of local players. Market penetration of CGM is currently at xx% and is expected to grow to xx% by 2033.
Dominant Regions & Segments in Diabetes Care Devices Industry in Vietnam
While data on regional dominance requires further analysis, the report will detail which regions have the highest adoption rates for diabetes care devices. The market segmentation analysis reveals a strong dominance of specific segments.
Monitoring Devices: Self-monitoring blood glucose (SMBG) devices currently dominate this segment due to their affordability and widespread accessibility. However, CGM is rapidly gaining traction, driven by its improved accuracy and convenience. Key drivers include rising awareness, government support for better diabetes management, and increasing affordability.
Management Devices: Insulin pumps and disposable pens are experiencing significant growth, driven by improved insulin delivery and enhanced patient convenience. The market for insulin syringes and cartridges is mature but remains essential for a sizeable portion of the population. Drivers include ease of use and availability.
Lancets: This segment is experiencing a relatively steady growth, directly correlated with the usage of SMBG devices.
Diabetes Care Devices Industry in Vietnam Product Innovations
Recent years have witnessed significant product innovations in the Vietnamese market, mirroring global trends. Continuous glucose monitoring (CGM) systems are becoming increasingly sophisticated, offering features like real-time data transmission and advanced analytical capabilities. Insulin pump technology is also evolving, incorporating features like remote monitoring and improved insulin delivery precision. These innovations are driving market growth by improving patient outcomes and enhancing the overall diabetes management experience, contributing to improved market fit and competitive advantage.
Report Scope & Segmentation Analysis
This report provides a comprehensive segmentation analysis of the Vietnam diabetes care devices market based on device type (Monitoring, Management), technology (CGM, SMBG, Insulin Pumps), end-user (hospitals, clinics, home-use), and distribution channels (pharmacies, online retailers). Each segment's market size, growth projections, and competitive dynamics are thoroughly examined in the full report, including a detailed breakdown of growth projections for each segment. For instance, the CGM segment is projected to experience significant growth due to its clinical advantages and rising patient awareness. The SMBG segment, while mature, maintains significant market share due to price accessibility.
Key Drivers of Diabetes Care Devices Industry in Vietnam Growth
Several key factors are driving the growth of the diabetes care devices industry in Vietnam:
- Rising Prevalence of Diabetes: The increasing prevalence of diabetes, fueled by lifestyle changes and an aging population, is the primary driver.
- Government Initiatives: Government programs aimed at improving healthcare access and diabetes management are boosting market growth.
- Technological Advancements: Innovations in CGM and insulin delivery systems are enhancing patient outcomes and driving adoption.
- Rising Healthcare Expenditure: Increased spending on healthcare is enabling greater access to advanced diabetes care devices.
Challenges in the Diabetes Care Devices Industry in Vietnam Sector
Despite the promising growth outlook, the Vietnamese diabetes care devices market faces several challenges:
- High Cost of Devices: The high cost of advanced devices like CGM systems limits accessibility for a significant portion of the population.
- Limited Healthcare Infrastructure: Uneven distribution of healthcare infrastructure across the country hampers market penetration in certain areas.
- Competition: Intense competition from both multinational and local players creates pricing pressures.
- Regulatory Hurdles: Navigating regulatory processes for new device approvals can be time-consuming.
Emerging Opportunities in Diabetes Care Devices Industry in Vietnam
The Vietnamese market presents several promising opportunities for growth:
- Expanding Rural Market Penetration: Focusing on expanding access to diabetes care devices in rural areas offers significant growth potential.
- Telemedicine Integration: Integrating diabetes care devices with telemedicine platforms can improve patient management and reduce hospital visits.
- Focus on Affordable Devices: Developing and distributing affordable diabetes care devices will cater to a larger segment of the population.
- Government Partnerships: Collaborating with the government on public health programs can increase market reach and awareness.
Leading Players in the Diabetes Care Devices Industry in Vietnam Market
- Roche
- Dexcom
- Ypsomed
- Abbott
- Eli Lilly
- Sanofi
- Medtronic
- Tandem
- Insulet
- Lifescan (Johnson & Johnson)
- Becton and Dickenson
- Novo Nordisk
Key Developments in Diabetes Care Devices Industry in Vietnam Industry
- May 2023: Partnership between VPA and Roche Diabetes Care Vietnam to improve healthcare access for children with Type 1 diabetes.
- January 2022: Grant from the Danish Ministry of Foreign Affairs to research gestational diabetes in Vietnam.
- March 2021: Abbott Vietnam introduces the FreeStyle Libre system.
Future Outlook for Diabetes Care Devices Industry in Vietnam Market
The future outlook for the Vietnamese diabetes care devices market is highly promising. Continued growth is anticipated, driven by increasing diabetes prevalence, technological advancements, and supportive government policies. Strategic partnerships, investment in affordable devices, and expansion into underserved markets will be crucial for capturing the significant market potential. The increasing integration of digital health technologies presents exciting opportunities for market expansion and improved patient care.
Diabetes Care Devices Industry in Vietnam Segmentation
-
1. Monitoring Devices
-
1.1. Self-monitoring Blood Glucose Devices
- 1.1.1. Glucometer Devices
- 1.1.2. Test Strips
- 1.1.3. Lancets
-
1.2. Continuous Blood Glucose Monitoring
- 1.2.1. Sensors
- 1.2.2. Durables
-
1.1. Self-monitoring Blood Glucose Devices
-
2. Management Devices
-
2.1. Insulin Pump
- 2.1.1. Insulin Pump Device
- 2.1.2. Insulin Pump Reservoir
- 2.1.3. Infusion Set
- 2.2. Insulin Syringes
- 2.3. Insulin Cartridges
- 2.4. Disposable Pens
-
2.1. Insulin Pump
Diabetes Care Devices Industry in Vietnam Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. South America
- 2.1. Brazil
- 2.2. Argentina
- 2.3. Rest of South America
-
3. Europe
- 3.1. United Kingdom
- 3.2. Germany
- 3.3. France
- 3.4. Italy
- 3.5. Spain
- 3.6. Russia
- 3.7. Benelux
- 3.8. Nordics
- 3.9. Rest of Europe
-
4. Middle East & Africa
- 4.1. Turkey
- 4.2. Israel
- 4.3. GCC
- 4.4. North Africa
- 4.5. South Africa
- 4.6. Rest of Middle East & Africa
-
5. Asia Pacific
- 5.1. China
- 5.2. India
- 5.3. Japan
- 5.4. South Korea
- 5.5. ASEAN
- 5.6. Oceania
- 5.7. Rest of Asia Pacific
Diabetes Care Devices Industry in Vietnam REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2019-2033 |
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025-2033 |
| Historical Period | 2019-2024 |
| Growth Rate | CAGR of 2.10% from 2019-2033 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Number of Preterm and Low-weight Births; Advanced Technology in Fetal and Prenatal Monitoring
- 3.3. Market Restrains
- 3.3.1. Stringent Regulatory Procedures
- 3.4. Market Trends
- 3.4.1. Management Devices Hold Highest Market Share in Vietnam Diabetes Care Devices Market
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Diabetes Care Devices Industry in Vietnam Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 5.1.1. Self-monitoring Blood Glucose Devices
- 5.1.1.1. Glucometer Devices
- 5.1.1.2. Test Strips
- 5.1.1.3. Lancets
- 5.1.2. Continuous Blood Glucose Monitoring
- 5.1.2.1. Sensors
- 5.1.2.2. Durables
- 5.1.1. Self-monitoring Blood Glucose Devices
- 5.2. Market Analysis, Insights and Forecast - by Management Devices
- 5.2.1. Insulin Pump
- 5.2.1.1. Insulin Pump Device
- 5.2.1.2. Insulin Pump Reservoir
- 5.2.1.3. Infusion Set
- 5.2.2. Insulin Syringes
- 5.2.3. Insulin Cartridges
- 5.2.4. Disposable Pens
- 5.2.1. Insulin Pump
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. North America
- 5.3.2. South America
- 5.3.3. Europe
- 5.3.4. Middle East & Africa
- 5.3.5. Asia Pacific
- 5.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 6. North America Diabetes Care Devices Industry in Vietnam Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 6.1.1. Self-monitoring Blood Glucose Devices
- 6.1.1.1. Glucometer Devices
- 6.1.1.2. Test Strips
- 6.1.1.3. Lancets
- 6.1.2. Continuous Blood Glucose Monitoring
- 6.1.2.1. Sensors
- 6.1.2.2. Durables
- 6.1.1. Self-monitoring Blood Glucose Devices
- 6.2. Market Analysis, Insights and Forecast - by Management Devices
- 6.2.1. Insulin Pump
- 6.2.1.1. Insulin Pump Device
- 6.2.1.2. Insulin Pump Reservoir
- 6.2.1.3. Infusion Set
- 6.2.2. Insulin Syringes
- 6.2.3. Insulin Cartridges
- 6.2.4. Disposable Pens
- 6.2.1. Insulin Pump
- 6.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 7. South America Diabetes Care Devices Industry in Vietnam Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 7.1.1. Self-monitoring Blood Glucose Devices
- 7.1.1.1. Glucometer Devices
- 7.1.1.2. Test Strips
- 7.1.1.3. Lancets
- 7.1.2. Continuous Blood Glucose Monitoring
- 7.1.2.1. Sensors
- 7.1.2.2. Durables
- 7.1.1. Self-monitoring Blood Glucose Devices
- 7.2. Market Analysis, Insights and Forecast - by Management Devices
- 7.2.1. Insulin Pump
- 7.2.1.1. Insulin Pump Device
- 7.2.1.2. Insulin Pump Reservoir
- 7.2.1.3. Infusion Set
- 7.2.2. Insulin Syringes
- 7.2.3. Insulin Cartridges
- 7.2.4. Disposable Pens
- 7.2.1. Insulin Pump
- 7.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 8. Europe Diabetes Care Devices Industry in Vietnam Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 8.1.1. Self-monitoring Blood Glucose Devices
- 8.1.1.1. Glucometer Devices
- 8.1.1.2. Test Strips
- 8.1.1.3. Lancets
- 8.1.2. Continuous Blood Glucose Monitoring
- 8.1.2.1. Sensors
- 8.1.2.2. Durables
- 8.1.1. Self-monitoring Blood Glucose Devices
- 8.2. Market Analysis, Insights and Forecast - by Management Devices
- 8.2.1. Insulin Pump
- 8.2.1.1. Insulin Pump Device
- 8.2.1.2. Insulin Pump Reservoir
- 8.2.1.3. Infusion Set
- 8.2.2. Insulin Syringes
- 8.2.3. Insulin Cartridges
- 8.2.4. Disposable Pens
- 8.2.1. Insulin Pump
- 8.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 9. Middle East & Africa Diabetes Care Devices Industry in Vietnam Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 9.1.1. Self-monitoring Blood Glucose Devices
- 9.1.1.1. Glucometer Devices
- 9.1.1.2. Test Strips
- 9.1.1.3. Lancets
- 9.1.2. Continuous Blood Glucose Monitoring
- 9.1.2.1. Sensors
- 9.1.2.2. Durables
- 9.1.1. Self-monitoring Blood Glucose Devices
- 9.2. Market Analysis, Insights and Forecast - by Management Devices
- 9.2.1. Insulin Pump
- 9.2.1.1. Insulin Pump Device
- 9.2.1.2. Insulin Pump Reservoir
- 9.2.1.3. Infusion Set
- 9.2.2. Insulin Syringes
- 9.2.3. Insulin Cartridges
- 9.2.4. Disposable Pens
- 9.2.1. Insulin Pump
- 9.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 10. Asia Pacific Diabetes Care Devices Industry in Vietnam Analysis, Insights and Forecast, 2019-2031
- 10.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 10.1.1. Self-monitoring Blood Glucose Devices
- 10.1.1.1. Glucometer Devices
- 10.1.1.2. Test Strips
- 10.1.1.3. Lancets
- 10.1.2. Continuous Blood Glucose Monitoring
- 10.1.2.1. Sensors
- 10.1.2.2. Durables
- 10.1.1. Self-monitoring Blood Glucose Devices
- 10.2. Market Analysis, Insights and Forecast - by Management Devices
- 10.2.1. Insulin Pump
- 10.2.1.1. Insulin Pump Device
- 10.2.1.2. Insulin Pump Reservoir
- 10.2.1.3. Infusion Set
- 10.2.2. Insulin Syringes
- 10.2.3. Insulin Cartridges
- 10.2.4. Disposable Pens
- 10.2.1. Insulin Pump
- 10.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis 2024
- 11.2. Company Profiles
- 11.2.1 Roche
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 Dexcom*List Not Exhaustive 7 2 Company Share Analysi
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 Ypsomed
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 Abbottt
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 Eli Lilly
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 Sanofi
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 Medtronic
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Tandem
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 Insulet
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 Lifescan (Johnson &Johnson)
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.11 Becton and Dickenson
- 11.2.11.1. Overview
- 11.2.11.2. Products
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Financials (Based on Availability)
- 11.2.12 Novo Nordisk
- 11.2.12.1. Overview
- 11.2.12.2. Products
- 11.2.12.3. SWOT Analysis
- 11.2.12.4. Recent Developments
- 11.2.12.5. Financials (Based on Availability)
- 11.2.1 Roche
List of Figures
- Figure 1: Global Diabetes Care Devices Industry in Vietnam Revenue Breakdown (Million, %) by Region 2024 & 2032
- Figure 2: Vietnam Diabetes Care Devices Industry in Vietnam Revenue (Million), by Country 2024 & 2032
- Figure 3: Vietnam Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Country 2024 & 2032
- Figure 4: North America Diabetes Care Devices Industry in Vietnam Revenue (Million), by Monitoring Devices 2024 & 2032
- Figure 5: North America Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Monitoring Devices 2024 & 2032
- Figure 6: North America Diabetes Care Devices Industry in Vietnam Revenue (Million), by Management Devices 2024 & 2032
- Figure 7: North America Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Management Devices 2024 & 2032
- Figure 8: North America Diabetes Care Devices Industry in Vietnam Revenue (Million), by Country 2024 & 2032
- Figure 9: North America Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Country 2024 & 2032
- Figure 10: South America Diabetes Care Devices Industry in Vietnam Revenue (Million), by Monitoring Devices 2024 & 2032
- Figure 11: South America Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Monitoring Devices 2024 & 2032
- Figure 12: South America Diabetes Care Devices Industry in Vietnam Revenue (Million), by Management Devices 2024 & 2032
- Figure 13: South America Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Management Devices 2024 & 2032
- Figure 14: South America Diabetes Care Devices Industry in Vietnam Revenue (Million), by Country 2024 & 2032
- Figure 15: South America Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Country 2024 & 2032
- Figure 16: Europe Diabetes Care Devices Industry in Vietnam Revenue (Million), by Monitoring Devices 2024 & 2032
- Figure 17: Europe Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Monitoring Devices 2024 & 2032
- Figure 18: Europe Diabetes Care Devices Industry in Vietnam Revenue (Million), by Management Devices 2024 & 2032
- Figure 19: Europe Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Management Devices 2024 & 2032
- Figure 20: Europe Diabetes Care Devices Industry in Vietnam Revenue (Million), by Country 2024 & 2032
- Figure 21: Europe Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Country 2024 & 2032
- Figure 22: Middle East & Africa Diabetes Care Devices Industry in Vietnam Revenue (Million), by Monitoring Devices 2024 & 2032
- Figure 23: Middle East & Africa Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Monitoring Devices 2024 & 2032
- Figure 24: Middle East & Africa Diabetes Care Devices Industry in Vietnam Revenue (Million), by Management Devices 2024 & 2032
- Figure 25: Middle East & Africa Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Management Devices 2024 & 2032
- Figure 26: Middle East & Africa Diabetes Care Devices Industry in Vietnam Revenue (Million), by Country 2024 & 2032
- Figure 27: Middle East & Africa Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Country 2024 & 2032
- Figure 28: Asia Pacific Diabetes Care Devices Industry in Vietnam Revenue (Million), by Monitoring Devices 2024 & 2032
- Figure 29: Asia Pacific Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Monitoring Devices 2024 & 2032
- Figure 30: Asia Pacific Diabetes Care Devices Industry in Vietnam Revenue (Million), by Management Devices 2024 & 2032
- Figure 31: Asia Pacific Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Management Devices 2024 & 2032
- Figure 32: Asia Pacific Diabetes Care Devices Industry in Vietnam Revenue (Million), by Country 2024 & 2032
- Figure 33: Asia Pacific Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Country 2024 & 2032
List of Tables
- Table 1: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 3: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 4: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Region 2019 & 2032
- Table 5: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Country 2019 & 2032
- Table 6: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 7: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 8: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Country 2019 & 2032
- Table 9: United States Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 10: Canada Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 11: Mexico Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 12: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 13: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 14: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Country 2019 & 2032
- Table 15: Brazil Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 16: Argentina Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 17: Rest of South America Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 18: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 19: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 20: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Country 2019 & 2032
- Table 21: United Kingdom Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 22: Germany Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 23: France Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 24: Italy Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 25: Spain Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 26: Russia Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 27: Benelux Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 28: Nordics Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 29: Rest of Europe Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 30: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 31: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 32: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Country 2019 & 2032
- Table 33: Turkey Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 34: Israel Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 35: GCC Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 36: North Africa Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 37: South Africa Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 38: Rest of Middle East & Africa Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 39: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 40: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 41: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Country 2019 & 2032
- Table 42: China Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 43: India Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 44: Japan Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 45: South Korea Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 46: ASEAN Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 47: Oceania Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 48: Rest of Asia Pacific Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Diabetes Care Devices Industry in Vietnam?
The projected CAGR is approximately 2.10%.
2. Which companies are prominent players in the Diabetes Care Devices Industry in Vietnam?
Key companies in the market include Roche, Dexcom*List Not Exhaustive 7 2 Company Share Analysi, Ypsomed, Abbottt, Eli Lilly, Sanofi, Medtronic, Tandem, Insulet, Lifescan (Johnson &Johnson), Becton and Dickenson, Novo Nordisk.
3. What are the main segments of the Diabetes Care Devices Industry in Vietnam?
The market segments include Monitoring Devices, Management Devices.
4. Can you provide details about the market size?
The market size is estimated to be USD 424.10 Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Number of Preterm and Low-weight Births; Advanced Technology in Fetal and Prenatal Monitoring.
6. What are the notable trends driving market growth?
Management Devices Hold Highest Market Share in Vietnam Diabetes Care Devices Market.
7. Are there any restraints impacting market growth?
Stringent Regulatory Procedures.
8. Can you provide examples of recent developments in the market?
May 2023: The VPA and Roche Diabetes Care Vietnam, represented by Roche Vietnam Company Limited, have partnered to improve healthcare access for disadvantaged children with Type 1 diabetes in Vietnam as part of the global initiative CDiC. Led by Novo Nordisk and Roche Diabetes Care, this program aims to expand healthcare access and provide insulin and supplies to children and young individuals with Type 1 diabetes up to age 25 in countries with limited resources.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Diabetes Care Devices Industry in Vietnam," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Diabetes Care Devices Industry in Vietnam report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Diabetes Care Devices Industry in Vietnam?
To stay informed about further developments, trends, and reports in the Diabetes Care Devices Industry in Vietnam, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
